I'm afraid about receiving my first treatment - any advice?

 

Q: I'm afraid about receiving my first treatment--any advice? 

A: It's normal to be anxious about your first chemotherapy or radiation therapy treatment. It's likely you've never experienced this treatment before. You probably have heard other peoples' stories about these treatments. Remember, this is your unique experience.

Even if you're well-informed about possible side effects from your prechemotherapy or radiation therapy teaching, you don't know how you will react specifically. You are taking control of your situation by starting treatment. You are now on the road to getting rid of the cancer. This is a very positive step. Most patients, after being initially scared and anxious, feel fine after their first treatment session. Now you'll know what to anticipate with the next treatment. You will also better know the nurses caring for you.

Our purpose is to promote the health of your mind, body, and spirit as you journey through this treatment. Your nurses recognize that this first treatment is your most difficult. We give you extra time on this important day so we can answer all your questions and provide the emotional support you need. There isn't anything you can't ask us and there isn't any emotion that we haven't experienced with our patients and their families. As you move into active treatment, you'll feel a sense of accomplishment and gaining control. That also helps you get through the first session.
--Bernice Crook, RN, OCN

You can reduce your anxiety about starting treatment by taking an active role.

Latest Cancer News
Vaccine Against HPV-16 Effective for Vulvar Intraepithelial Neoplasia

November 6, 2009 — Researchers from the Netherlands have reported that vaccination with synthetic long-peptides against human papillomavirus (HPV)-16 was effective in treating vulvar intraepithelial neoplasia (VIN). The details of this study were published in the November 5, 2009 issue of the New England Journal of Medicine.

Small HER2-positive Breast Cancers Have a Higher Risk of Recurrence

November 6, 2009 — Researchers from the M. D. Anderson Cancer Center and the University of Milan, Italy, have reported that women with Stage T1a,b, N0M0 HER2-positive breast cancers have a have a high recurrence rate without the administration of adjuvant chemotherapy or Herceptin® (trastuzumab). These data suggest that these women should be treated with Herceptin®-based adjuvant chemotherapy. The details of these two studies appeared in early online publications on November 2, 2009 in the Journal of Clinical Oncology.

Alcohol May Reduce Risk of Thyroid Cancer

November 6, 2009 — Researchers affiliated with the NIH-AARP Diet and Health Study have reported that alcohol intake may reduce the risk of thyroid cancer. The details of this study appeared in the November 4, 2009 issue of the British Journal of Cancer.

Select news items provided by Reuters Health